Mail

UK markets close in 51 minutes

FTSE 100
8,141.38
+62.52(+0.77%)
FTSE 250
19,835.65
+233.67(+1.19%)
AIM
755.75
+2.63(+0.35%)
GBP/EUR
1.1677
+0.0021(+0.18%)
GBP/USD
1.2484
-0.0027(-0.21%)
Bitcoin GBP
51,536.85
+585.55(+1.15%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Fresenius Medical Care AG (FMCQF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

36.95

0.00

(0.00%)

As of 02:52PM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	10.84B
Enterprise value	22.09B
Trailing P/E	20.31
Forward P/E	10.65
PEG ratio (5-yr expected)	0.40
Price/sales (ttm)	0.52
Price/book (mrq)	0.74
Enterprise value/revenue	1.14
Enterprise value/EBITDA	6.88

Trading information

Stock price history

Beta (5Y monthly)	0.93
52-week change ³	-20.47%
S&P500 52-week change ³	21.08%
52-week high ³	49.86
52-week low ³	34.33
50-day moving average ³	39.39
200-day moving average ³	41.39

Share statistics

Avg vol (3-month) ³	72
Avg vol (10-day) ³	70
Shares outstanding ⁵	293.41M
Implied shares outstanding ⁶	321.06M
Float ⁸	198.94M
% held by insiders ¹	32.17%
% held by institutions ¹	39.07%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	1.28
Forward annual dividend yield ⁴	3.47%
Trailing annual dividend rate ³	1.19
Trailing annual dividend yield ³	3.22%
5-year average dividend yield ⁴	1.30
Payout ratio ⁴	65.88%
Dividend date ³	N/A
Ex-dividend date ⁴	17 May 2024
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	2.57%
Operating margin (ttm)	9.93%

Management effectiveness

Return on assets (ttm)	2.73%
Return on equity (ttm)	4.84%

Income statement

Revenue (ttm)	19.45B
Revenue per share (ttm)	66.30
Quarterly revenue growth (yoy)	-0.20%
Gross profit (ttm)	N/A
EBITDA	2.38B
Net income avi to common (ttm)	499M
Diluted EPS (ttm)	1.82
Quarterly earnings growth (yoy)	35.40%

Balance sheet

Total cash (mrq)	1.56B
Total cash per share (mrq)	5.31
Total debt (mrq)	12.05B
Total debt/equity (mrq)	81.28%
Current ratio (mrq)	1.42
Book value per share (mrq)	46.42

Cash flow statement

Operating cash flow (ttm)	2.63B
Levered free cash flow (ttm)	1.33B